All
Open, Non-Judgmental Communication Is Key in Transgender Cancer Care
March 1st 2023Oncologists suggest that treatment decisions made for transgender cancer patients should not be made through the lens of their gender identity but should encourage physicians to discuss a wider variety of treatment options with all patients.
Stepping Up Again for Hereditary Cancer Prevention
February 25th 2023On Feb. 6, HB 2783 was introduced into the Arizona House. Hopefully this bill will help address some of the issues surrounding genetic testing, genetic counseling, and insurance coverage for those who might be at risk for hereditary cancer. My wife died of a cancer that was totally preventable. Nobody should die of a preventable cancer.
Advocating for Biomarker Testing During a Lung Cancer Diagnosis
February 24th 2023As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, on behalf of KRAS Kickers, about what biomarker testing is and why patients with lung cancer should advocate for themselves during that process.
FDA Grants Keytruda, Cancer Vaccine Combo Breakthrough Therapy Designation for Melanoma
February 23rd 2023The designation is based on study findings demonstrating that the cancer vaccine-Keytruda combination reduces the risk of recurrence or death by 44% in the adjuvant setting for patients with melanoma.